Diabetes management in the USA and England: Comparative analysis of national surveys

Journal of the Royal Society of Medicine

Volumn 99, Issue 9, 2006, Pages 463-469

  Mainous III, Arch G ^a   Diaz, Vanessa A ^a   Saxena, Sonia ^b   Baker, Richard ^c   Everett, Charles J ^a   Koopman, Richelle J ^a   Majeed, Azeem ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN;

ADULT; BLOOD PRESSURE REGULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; REVIEW; UNITED KINGDOM; UNITED STATES;

EID: 33749622432     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.99.9.463     Document Type: Review

References (31)

1. Cohen RA, Coraty-Nelson Z. Health Insurance Coverage: Estimates From The National Health Interview Survey, 2003. June 2004[http://www.cdc.gov/nchs/nhis. htm]
2. Shaw JC Oh. Canada: comparing single-payer health care with practice in the United States. Am J Med 2005;118:1064-6
3. Brown LD. Comparing health systems in four countries: lessons for the United States. Am J Public Health 2003;93:52-6
4. Light DW. Universal health care: lessons from the British experience. Am J Public Health 2003;93:25-30
5. Feachem RG, Sekhri NK, White KL. Getting more for their dollar: a comparison of the NHS with California's Kaiser Permanente. BMJ 2002;324:135-41
6. Ham C, York N, Sutch S, Shaw R. Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: analysis of routine data. BMJ 2003;327:1257
7. Himmelstein DU, Woolhandler S. Getting more for their dollar: Kaiser v the NHS. Price adjustments falsify comparison. BMJ 2002;324:1332
8. Talbot-Smith A, Gnani S, Pollock AM, Gray DP. Questioning the claims from Kaiser. Br J Gen Pract 2004;54:415-21
9. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. Diabetes Care 1998;21:518-24
10. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 1997; 20:735-44
11. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2000;23:S32-42
12. Department of Health. National Service Framework For Diabetes: Standards. London: DoH, 2001 [http://www.doh.gov.uk/nsf/diabetes/pdfs/diabetesnsf.pdf]
13. Diabetes UK. Recommendations for the Management of Diabetes in Primary Care, 2nd edn, revised. London: Diabetes UK, 2000 [http://www.diabetes.org/ clinicalrecommendations/Supplement101/S33.htm]
14. Cowie CC, Rust KF, Byrd-Holt D, et al. Prevalence of diabetes and impaired fasting glucose in adults-United States, 1999-2000. MMWR 2003;52:833-7
15. Mainous AG III, Koopman RJ, Gill JM, Baker R, Pearson WS. The relationship between continuity of care and diabetes control: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health 2004;94:66-70
16. Koopman RJ, Mainous AG III, Baker R, Gill JM, Gilbert GE. Continuity of care and recognition of diabetes, hypertension and hypercholesterolemia. Arch Intern Med 2003;163:1357-61
17. Italian Society of Diabetology. Risultati dello studio pilota sul controllo di qualita' del dosaggio dell'emoglbina glicosilata. Diabete 1994;6:89-92
18. Weykamp CW, Penders TJ, Muskiet FAJ, van der Slik W. Glycohemoglobin: comparison of 12 analytic methods, applied to lyophilized haemolysates by 101 laboratories in an external quality assurance programme. Ann Clin Biochem 1993;30:169-74
19. John WG. Performance of glycated haemoglobin analysis: data from the UK national external quality assessment scheme (UK NEQAS). Biochim Clin 1989;13(suppl 8):253
20. Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1C) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23:187-91
21. Hanson RL, Nelson RG, McCance DR, et al. Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 1993; 153:2133-40
22. Park PJ, Griffin SJ, Sargeant DM, Wareham NJ. The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care 2002;25:984-8
23. Guidelines for good practice in the diagnosis and treatment of NIDDM. Report of a Joint working Party of the British Diabetic Association, The Research Unit of the Royal College of Physicians and the Royal College of General Practitioners. J R Coll Physicians Land 1993;27:259-66
24. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004;19:1175-80
25. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1999;22:S32-41
26. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27:S15-35
27. National Institute for Clinical Excellence. Management of type 2 diabetes. Management of blood glucose, inherited Clinical Guideline G. London: NICE, 2002 [http://www.nice.org.uk]
28. National Institute for Clinical Excellence. Management of type 2 diabetes. Management of blood pressure and blood lipids. Inherited Clinical Guideline H. London: NICE, 2002 [http://www.nice.org.uk]
29. Private Medical Insurance UK Market Sector Report. London: Laing & Buisson, 2001 [http:www.laingbuisson.co.uk]
30. Institute of Medicine. Care Without Coverage: Too Little, Too Late. Washington: National Academy Press, 2002
31. Roland M. Linking physicians' pay to the quality of care-a major experiment in the United Kingdom. N Engl J Med 2004;351:1448-54